Eyes open to stem cells: safety trial may pave the way for cell therapy to treat retinal disease in patients

A clinical trial using human embryonic stem cell (hESC) therapy for an inherited retinal degenerative disease is about to commence. The Advanced Cell Technology (ACT) trial will treat patients with Stargardt's macular dystrophy using transplanted retinal pigment epithelium derived from hESCs. C...

Descripción completa

Detalles Bibliográficos
Autores principales: Medina, Reinhold J, Archer, Desmond B, Stitt, Alan W
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3340556/
https://www.ncbi.nlm.nih.gov/pubmed/22152341
http://dx.doi.org/10.1186/scrt88

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3340556/
https://www.ncbi.nlm.nih.gov/pubmed/22152341
http://dx.doi.org/10.1186/scrt88

Ejemplares similares